<?xml version="1.0" encoding="UTF-8"?>
<ref id="B74-pharmaceuticals-13-00096">
 <label>74.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chen</surname>
    <given-names>Y.-C.</given-names>
   </name>
   <name>
    <surname>Yoo</surname>
    <given-names>D.H.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>C.K.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>K.-J.</given-names>
   </name>
   <name>
    <surname>Won</surname>
    <given-names>J.-E.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>W.-S.</given-names>
   </name>
   <name>
    <surname>Zhong</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Nicolay</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Walls</surname>
    <given-names>C.D.</given-names>
   </name>
   <name>
    <surname>Tanaka</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Safety of baricitinib in East Asian patients with moderate-to-severe active rheumatoid arthritis: An integrated analysis from clinical trials</article-title>
  <source>Int. J. Rheum. Dis.</source>
  <year>2020</year>
  <volume>23</volume>
  <fpage>65</fpage>
  <lpage>73</lpage>
  <pub-id pub-id-type="doi">10.1111/1756-185X.13748</pub-id>
  <?supplied-pmid 31729189?>
  <pub-id pub-id-type="pmid">31729189</pub-id>
 </element-citation>
</ref>
